Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Immunocyte single cell analysis of vaccine-induced narcolepsy

Author

  • Alexander Lind
  • Falastin Salami
  • Anne-Marie Landtblom
  • Lars Palm
  • Åke Lernmark
  • Jörgen Adolfsson
  • Helena Elding Larsson

Summary, in English

Increased incidence of narcolepsy type 1 (NT1) was observed following Pandemrix®‐vaccination, initiated as a preventive measure against the 2009 Influenza pandemic. Here, single cell analysis was conducted to suggest a lower number of CD8+CD27+ T cells among these patients. These findings provide understanding into the autoimmune pathogenesis of NT1.

Department/s

  • Paediatric Endocrinology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • Diabetes and Celiac Unit

Publishing year

2021

Language

English

Pages

247-249

Publication/Series

European Journal of Immunology

Volume

51

Issue

1

Document type

Journal article (letter)

Publisher

John Wiley and Sons

Topic

  • Immunology in the medical area

Status

Published

Research group

  • Paediatric Endocrinology
  • Diabetes and Celiac Unit

ISBN/ISSN/Other

  • ISSN: 1521-4141